196 related articles for article (PubMed ID: 24817520)
1. Low body mass index is associated with adverse oncological outcomes following radical prostatectomy in Korean prostate cancer patients.
Koo KC; Yoon YE; Rha KH; Chung BH; Yang SC; Hong SJ
Int Urol Nephrol; 2014 Oct; 46(10):1935-40. PubMed ID: 24817520
[TBL] [Abstract][Full Text] [Related]
2. Impact of Body Mass Index on Oncological Outcomes of Prostate Cancer Patients after Radical Prostatectomy.
Yu YD; Byun SS; Lee SE; Hong SK
Sci Rep; 2018 Aug; 8(1):11962. PubMed ID: 30097640
[TBL] [Abstract][Full Text] [Related]
3. Impact of body mass index on clinicopathological outcome and biochemical recurrence after radical prostatectomy.
Narita S; Mitsuzuka K; Yoneyama T; Tsuchiya N; Koie T; Kakoi N; Kawamura S; Kaiho Y; Ohyama C; Tochigi T; Yamaguchi T; Habuchi T; Arai Y
Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):271-6. PubMed ID: 23752230
[TBL] [Abstract][Full Text] [Related]
4. Body mass index is associated with higher Gleason score and biochemical recurrence risk following radical prostatectomy in Chinese men: a retrospective cohort study and meta-analysis.
Bai PD; Hu MB; Xu H; Zhu WH; Hu JM; Yang T; Jiang HW; Ding Q
World J Surg Oncol; 2015 Nov; 13():311. PubMed ID: 26542246
[TBL] [Abstract][Full Text] [Related]
5. Is body mass index associated with pathological outcomes after radical prostatectomy in Korean men?
Lee SE; Lee WK; Jeong MS; Abdullajanov M; Kim DS; Park HZ; Jeong SJ; Yoon CY; Byun SS; Choe G; Hong SK
BJU Int; 2011 Apr; 107(8):1250-5. PubMed ID: 20880194
[TBL] [Abstract][Full Text] [Related]
6. Obesity and long-term survival after radical prostatectomy.
Chalfin HJ; Lee SB; Jeong BC; Freedland SJ; Alai H; Feng Z; Trock BJ; Partin AW; Humphreys E; Walsh PC; Han M
J Urol; 2014 Oct; 192(4):1100-4. PubMed ID: 24769031
[TBL] [Abstract][Full Text] [Related]
7. Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study.
Maj-Hes AB; Mathieu R; Özsoy M; Soria F; Moschini M; Abufaraj M; Briganti A; Roupret M; Karakiewicz PI; Klatte T; Shariat SF
Urol Oncol; 2017 Jul; 35(7):460.e1-460.e8. PubMed ID: 28460801
[TBL] [Abstract][Full Text] [Related]
8. Correlation of High Body Mass Index With More Advanced Localized Prostate Cancer at Radical Prostatectomy Is Not Reflected in PSA Level and PSA Density but Is Seen in PSA Mass.
Kryvenko ON; Epstein JI; Meier FA; Gupta NS; Menon M; Diaz M
Am J Clin Pathol; 2015 Aug; 144(2):271-7. PubMed ID: 26185312
[TBL] [Abstract][Full Text] [Related]
9. Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy.
Tomaszewski JJ; Chen YF; Bertolet M; Ristau BT; Woldemichael E; Nelson JB
Urology; 2013 May; 81(5):992-6. PubMed ID: 23453649
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature.
Faisal FA; Sundi D; Pierorazio PM; Ball MW; Humphreys EB; Han M; Epstein JI; Partin AW; Carter HB; Bivalacqua TJ; Schaeffer EM; Ross AE
BJU Int; 2014 Dec; 114(6b):E120-E129. PubMed ID: 24731026
[TBL] [Abstract][Full Text] [Related]
11. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
12. Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy.
van Roermund JG; Kok DE; Wildhagen MF; Kiemeney LA; Struik F; Sloot S; van Oort IM; Hulsbergen-van de Kaa CA; van Leenders GJ; Bangma CH; Witjes JA
BJU Int; 2009 Aug; 104(3):321-5. PubMed ID: 19220264
[TBL] [Abstract][Full Text] [Related]
13. Obesity, risk of biochemical recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database.
Freedland SJ; Branche BL; Howard LE; Hamilton RJ; Aronson WJ; Terris MK; Cooperberg MR; Amling CL; Kane CJ;
BJU Int; 2019 Jul; 124(1):69-75. PubMed ID: 30347135
[TBL] [Abstract][Full Text] [Related]
14. Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression.
Schiffmann J; Salomon G; Tilki D; Budäus L; Karakiewicz PI; Leyh-Bannurah SR; Pompe RS; Haese A; Heinzer H; Huland H; Graefen M; Tennstedt P
Urol Oncol; 2017 May; 35(5):243-249. PubMed ID: 28161322
[TBL] [Abstract][Full Text] [Related]
15. Overweight and obesity in men with prostate cancer do not constitute risk factors for biochemical recurrence.
Leal-García M; Canto P; Cárdenas-Cárdenas E; Feria-Bernal G; García-García E; Méndez JP
Aging Male; 2020 Dec; 23(5):1283-1288. PubMed ID: 32410487
[TBL] [Abstract][Full Text] [Related]
16. Impact of body mass index on outcomes of laparoscopic radical prostatectomy with long-term follow-up.
Gözen AS; Akin Y; Özden E; Ates M; Hruza M; Rassweiler J
Scand J Urol; 2015 Feb; 49(1):70-6. PubMed ID: 25130508
[TBL] [Abstract][Full Text] [Related]
17. Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies.
Ferro M; Terracciano D; Musi G; de Cobelli O; Vartolomei MD; Damiano R; Cantiello F; Buonerba C; Morelli M; Mistretta FA; Luzzago S; Perdonà S; Del Prete P; Del Giudice F; Busetto GM; Porreca A; Autorino R; Manfredi M; Porpiglia F; Muto M; Loizzo D; Ditonno P; Battaglia M; Lucarelli G
Urol Int; 2022; 106(1):75-82. PubMed ID: 34167120
[TBL] [Abstract][Full Text] [Related]
18. Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database.
Ho T; Gerber L; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
Eur Urol; 2012 Nov; 62(5):910-6. PubMed ID: 22921964
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
[TBL] [Abstract][Full Text] [Related]
20. Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy.
Amling CL; Kane CJ; Riffenburgh RH; Ward JF; Roberts JL; Lance RS; Friedrichs PA; Moul JW
Urology; 2001 Nov; 58(5):723-8. PubMed ID: 11711349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
